首页> 美国卫生研究院文献>JIMD Reports >Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C
【2h】

Preliminary Results on Long-Term Potentiation-Like Cortical Plasticity and Cholinergic Dysfunction After Miglustat Treatment in Niemann-Pick Disease Type C

机译:Miglustat治疗C型尼曼-匹克病后长期增强类似皮质可塑性和胆碱能功能障碍的初步结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Niemann-Pick disease type C (NPC) is a rare autosomal recessive lysosomal storage disorder, which manifests clinically with a wide range of neurological signs and symptoms. We assessed multiple neurological, neuropsychological and neurophysiological biomarkers using a transcranial magnetic stimulation (TMS) multi-paradigm approach in two patients with NPC carrying a homozygous mutation in the NPC1 gene, and in two heterozygous family members.We assessed short-interval intracortical inhibition (SICI), intracortical facilitation (ICF), long-interval intracortical inhibition (LICI), short-latency afferent inhibition (SAI) and long-term potentiation (LTP)-like cortical plasticity with a paired associative stimulation (PAS) protocol.Baseline SAI and LTP-like plasticity were impaired in both patients with NPC and in the symptomatic heterozygous NPC1 gene mutation carrier. Only a limited decrease in SICI and ICF was observed, while LICI was within normal range in all subjects at baseline. After 12 months of treatment with miglustat, a considerable improvement in SAI and LTP-like plasticity was observed in both patients with NPC. In conclusion, these biomarkers could help to confirm the diagnosis of NPC, and may give an indication of prognostic outcomes in pharmacological trials. >Electronic supplementary material: The online version of this chapter (doi:10.1007/8904_2016_33) contains supplementary material, which is available to authorized users.
机译:尼曼-匹克病C型(NPC)是一种罕见的常染色体隐性溶酶体贮积病,在临床上表现为多种神经系统症状和体征。我们使用经颅磁刺激(TMS)多范式方法评估了两名在NPC1基因中携带纯合子突变的NPC患者和两名杂合子家族成员的多种神经,神经心理学和神经生理生物标志物。我们评估了短间隔皮质内抑制( SICI),皮层内促进(ICF),长间隔皮层内抑制(LICI),短时延传入抑制(SAI)和长期增强(LTP)样皮质可塑性,并具有配对联想刺激(PAS)协议。 NPC患者和有症状的杂合NPC1基因突变携带者均会损害LTP和LTP样可塑性。在基线时,所有受试者的SICI和ICF仅观察到有限的下降,而LICI在正常范围内。用米格司他治疗12个月后,在两名NPC患者中均观察到SAI和LTP样可塑性的显着改善。总之,这些生物标志物可以帮助确认NPC的诊断,并可能在药理试验中提供预后指标。 >电子补充材料::本章的在线版本(doi:10.1007 / 8904_2016_33)包含补充材料,授权用户可以使用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号